|
|
|
|
| LEADER |
04049nma a2201165 u 4500 |
| 001 |
EB002045208 |
| 003 |
EBX01000000000000001188874 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
220822 ||| eng |
| 020 |
|
|
|a books978-3-0365-4008-5
|
| 020 |
|
|
|a 9783036540078
|
| 020 |
|
|
|a 9783036540085
|
| 100 |
1 |
|
|a Thongprayoon, Charat
|
| 245 |
0 |
0 |
|a Progress and Recent Advances in Solid Organ Transplantation
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2022
|
| 300 |
|
|
|a 1 electronic resource (188 p.)
|
| 653 |
|
|
|a hematuria
|
| 653 |
|
|
|a post traumatic growth
|
| 653 |
|
|
|a outcome
|
| 653 |
|
|
|a diarrhea
|
| 653 |
|
|
|a desensitization
|
| 653 |
|
|
|a complications
|
| 653 |
|
|
|a antibody-mediated rejection
|
| 653 |
|
|
|a MINI
|
| 653 |
|
|
|a kidney transplantation
|
| 653 |
|
|
|a nephrectomy
|
| 653 |
|
|
|a tocilizumab
|
| 653 |
|
|
|a drug dosing
|
| 653 |
|
|
|a renal transplantation
|
| 653 |
|
|
|a small intestinal bacterial overgrowth
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a distress
|
| 653 |
|
|
|a big data
|
| 653 |
|
|
|a recurrent primary disease
|
| 653 |
|
|
|a sickle cell
|
| 653 |
|
|
|a immunosuppression
|
| 653 |
|
|
|a parathyroid hormone
|
| 653 |
|
|
|a Contrast-enhanced ultrasound
|
| 653 |
|
|
|a graft order
|
| 653 |
|
|
|a CPC
|
| 653 |
|
|
|a DCPR
|
| 653 |
|
|
|a ESAS
|
| 653 |
|
|
|a hand-assisted laparoscopic nephrectomy
|
| 653 |
|
|
|a anti-HLA alloantibody
|
| 653 |
|
|
|a end-stage renal disease
|
| 653 |
|
|
|a outcomes
|
| 653 |
|
|
|a kidney perfusion
|
| 653 |
|
|
|a body composition
|
| 653 |
|
|
|a kidney donation
|
| 653 |
|
|
|a Pharmacology / bicssc
|
| 653 |
|
|
|a parathyroidectomy
|
| 653 |
|
|
|a sequence
|
| 653 |
|
|
|a network analysis
|
| 653 |
|
|
|a pancreas transplantation
|
| 653 |
|
|
|a pharmacokinetics
|
| 653 |
|
|
|a bone fractures
|
| 653 |
|
|
|a kidney function
|
| 653 |
|
|
|a simultaneous pancreas-kidney transplantation
|
| 653 |
|
|
|a dyslipidemia
|
| 653 |
|
|
|a mineral bone disorder
|
| 653 |
|
|
|a transplantation
|
| 653 |
|
|
|a chronic kidney disease
|
| 653 |
|
|
|a tacrolimus
|
| 653 |
|
|
|a clazakizumab
|
| 653 |
|
|
|a bioimpedance analysis
|
| 653 |
|
|
|a cholesterol
|
| 653 |
|
|
|a survival
|
| 653 |
|
|
|a delayed graft function
|
| 653 |
|
|
|a C/D ratio
|
| 653 |
|
|
|a living donation
|
| 653 |
|
|
|a psychiatric morbidity
|
| 653 |
|
|
|a anxiety
|
| 653 |
|
|
|a lean body mass index
|
| 653 |
|
|
|a demoralization
|
| 653 |
|
|
|a cold ischemia time
|
| 653 |
|
|
|a alexithymia
|
| 653 |
|
|
|a tacrolimus C/D ratio
|
| 653 |
|
|
|a hydrogen
|
| 653 |
|
|
|a sickle cell disease
|
| 653 |
|
|
|a liver transplantation
|
| 653 |
|
|
|a metabolism
|
| 653 |
|
|
|a Eurotransplant Senior Program
|
| 653 |
|
|
|a intensive care unit
|
| 653 |
|
|
|a LDL-C
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a osteoporosis
|
| 700 |
1 |
|
|a Cheungpasitporn, Wisit
|
| 700 |
1 |
|
|a Kaewput, Wisit
|
| 700 |
1 |
|
|a Thongprayoon, Charat
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-4008-5
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/5466
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/84483
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 615
|
| 082 |
0 |
|
|a 580
|
| 520 |
|
|
|a There have been recent significant improvements in the short-term survival of solid organ transplantation patients due to advances in immunosuppression and transplant techniques. However, long-term graft survival has still lagged behind other outcomes and has now become one of the main problems in solid organ transplantation.For this Special Issue, we invited researchers and clinicians to submit studies on solid organ transplantation. These have provided us with additional knowledge and skills that will ultimately help us to improve outcomes after solid organ transplantation.
|